UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Frederick Beddingfield, MD, PhD

Print
Email

Frederick Beddingfield, MD, PhD

UCLA Physician Frederick Beddingfield, MD, PhD specializes in Dermatology.
Specialty
Dermatology
Gender
Male
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
State License Number
A51146
Contact
(310) 825-6911 Information and referral
PRACTICE LOCATION
Peter Morton Medical Building
200 UCLA Medical Plaza, Suite 465
Los Angeles, CA 90095
MEDICAL BOARD CERTIFICATION
Dermatology, American Board of Dermatology, 2001, 2009
Emergency Medicine, American Board of Emergency Medicine, 1995, 2005
EDUCATION
Fellowship
Dermatology Surgery/Mohs Micrographic Surgery, UCLA School of Medicine, 2002 - 2003
Residency
Dermatology, Harbor - UCLA Medical Center, 1998 - 2001
Medicine/Emergency Medicine, Harbor - UCLA Medical Center, 1992 - 1995
Internship
Medicine/Emergency Medicine, Harbor - UCLA Medical Center, 1991 - 1992
Medical Degree
MD, University of North Carolina, Chapel Hill, School of Medicine, 1991
CLINICAL INTEREST
Aesthetic Dermatology (BOTOX, Fillers, and Chemical Peels), Derma Filler Injection, Laser, MOH's Micrographic Surgery, Skin Cancer
AFFILIATION
MORE INFORMATION
Additional Information

Frederick Beddingfield, MD, PhD, is an Assistant Clinical Professor of Medicine/Dermatology at the David Geffen School of Medicine at UCLA. He simultaneously completed a residency in dermatology at UCLA and a doctorate in policy analysis at the RAND Graduate School of Policy Studies in Santa Monica, California, as part of the UCLA STAR Program. Subsequently, he completed the UCLA dermatologic, cosmetic, and laser surgery fellowship prior to joining the UCLA faculty. Dr. Beddingfield holds a medical degree with honors from the University of North Carolina at Chapel Hill School of Medicine. Prior to his dermatology training he completed a residency and chief resident fellowship in emergency medicine at Harbor-UCLA Medical Center. He is board certified in both dermatology and emergency medicine and is a fellow of the American Academy of Dermatology and the American College of Mohs Micrographic Surgery and Cutaneous Oncology.

In addition to his work at UCLA, Dr Beddingfield is the Chief Medical Officer of Kythera Biopharmaceuticals, Inc. a biopharmaceutical company focused on the discovery and development of novel prescription products for aesthetic medicine. Prior to this, he also worked at Allergan, Inc. for ten years where he served as Vice President and Head of the Dermatology and Aesthetics Research and Development where he led the development of worldwide BOTOX; Cosmetic®, Juvederm®, Latisse and many other products. Dr. Beddingfield is an innovative and internationally respected dermatologist and dermatologic surgeon, lecturer, and has been responsible for the development of numerous drugs and medical devices in common use in dermatology and plastic surgery clinics worldwide.

Awards & Recognition
Elle Genius Award, 2009
Publications
1. Lupo MP, Smith SR, Thomas JA, Murphy DK, Beddingfield FC III. Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg. 2008 Jan;121(1):289-97.
2. Beddingfield FC III, Kim J. Fillers in Ethnic Skin. Aesthetics and Cosmetic Surgery for Darker Skin Types. Grimes PE ed., Lippincott Williams & Wilkins. 2007.
3. Glaser DA, Kowalski JK, Ravelo A, Weng EY, Beddingfield FC III. Functional and Dermatology-Specific Quality of Life Benefits with Repeated Botulinum Toxin Type A Treatment of Primary Axillary Hyperhidrosis Over Four Years. JAAD 2007
4. Losina E, Walensky RP, Geller A, Beddingfield FC III, Wolf LL, Gilchrest BA, Freedberg KA. Visual Screening for Malignant Melanoma: A Cost-effectiveness Analysis. Arch Dermatol. 2007;143:21-28.
5. Klein AW, Beddingfield FC III. Other Temporary or Permanent Injectable Fillers. Tissue Augmentation in Clinical Practice: Second Edition. Klein AW ed., Marcel Dekker, Inc., New York. 2005
6. Schpall R, Beddingfield FC III, Watson D, Lask GP. Microdermabrasion: A Review. Facial Plastic Surgery 2004: 20:1; 47-50.
7. Kim J, Beddingfield FC III, Lask GP. Non-ablative resurfacing lasers. In Principles and Practices in Cutaneous Laser Surgery. Kauvar ANB ed., Marcel Dekker, Inc., New York. 2001.
8. Kim J, Beddingfield FC III, Lask GP. Non-ablative facial resurfacing. In Operative Techniques in Oculoplastic, Orbital, and Reconstructive Surgery. Taylor and Frances, Inc. Philadelphia, 2001

Link to MyPubMed for more publications.

Selected Lectures and Scientific Presentations:

1. Total Facial Rejuvenation, Hawaii Dermatology, Kona, HI, March, 2008.
2. Fllers for Total Facial Rejuvenation. AAD, San Antonio, TX, February, 2008.
3. Photoaging and Procedures: Cosmeceuticals. AAD, San Antonio, TX, February, 2008 and Washington, DC, February 2007.
4. Dermal Fillers, UCLA Dermatology, January, 2008, March 2007.
5. Update on Botulinum Toxins. International Society for Cosmetic and Laser Surgery. Las Vegas, NV, November 2007
6. Dermasurgery Pearls: Periorbital Rejuvenation. American Society for Dermatologic Surgery, Chicago, IL, October 2007.
7. Patients’ Self-Perception of Age of Appearance Following Treatment with Botulinum Toxin Type A for Upper Facial Rhytids: Pooled Results from 6 Studies. World Congress of Dermatology, Buenos Aires, October 2007.
8. Functional and dermatology-specific quality of life benefits with botulinum toxin type A treatment of primary axillary hyperhidrosis over four years.
9. Hawaii Dermatology Seminar. Maui, HI, March 2007 and World Congress of Dermatology, Buenos Aires, October 2007.
10. BOTOX and the Evolution of Medical Aesthetics, SRI 4th Annual Cosmeceuticals Conference, NYC, NY, June 2007.
11. Cosmeceuticals and Ethnic Skin, SRI 4th Annual Cosmeceuticals Conference, NYC, NY, June 2007.
12. BOTOX and Hyperhidrosis: Hawaii Dermatology Seminar, Maui, HI, March 2007.
13. BOTOX and Depression: Hawaii Dermatology Seminar, Maui, HI, March 2007.
14. The Hollywood Perspective: Botulinum Toxins and Fillers. AAD Washington, DC, February 2007.
15. Cosmetic Treatments For Ethnic Skin: Botulinum Toxins and Fillers. AAD Washington, DC, February 2007.
16. Diffusion halos and Botulinum toxins. American Society for Dermatologic Surgery, Palm Springs, October 2006.

Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Dr. Frederick Beddingfield,  click here to update your profile.